← Back to headlines
Clarivate Stock Jumps 16% Following $600M Sale of Life Sciences Segment
Clarivate's shares surged by 16% after the company announced the sale of its life sciences segment for $600 million. This financial move has significantly impacted the company's market performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Pagcor Launches P60-M Scholarship Fund for Bulacan Students
just now
Manila Water Ensures 24/7 Service Amid El Niño Through Low Nonrevenue Water
just now
Nigeria's Galaxy Backbone Attracts Banks After Data Localization Directive
just now